An observation from the intake side of Indian oncology - and one quiet response that has begun to take shape.
A senior medical oncologist at a tertiary cancer centre - pick any large Indian city - opens her OPD at nine and finds twenty-three names on her list. New cases. Each has travelled some distance to reach her. Each carries a folder, or a phone, or both.
The folders are kind to her in some ways and unkind in others. They contain everything. Path reports from one lab, immunohistochemistry from another. A PET-CT from a third centre. Discharge summaries from a surgery that happened in a fourth. Photographs of prescriptions on hotel stationery. Handwritten notes from a previous consultation, in a hand that is not the patient's own.
By eleven, she has seen six patients. For each one, ninety minutes have gone into the records before any clinical conversation could begin. The conversation itself, when it arrives, is shorter than the records review that preceded it.
The patient has done her best. She has carried what she was given, in the form it was given to her. The oncologist has done her best. She is reading every page with care because the case deserves it. The hospitals upstream have done their best, within the protocols and the workflow each of them runs.
Yet something in the picture asks to be looked at gently. The senior consultant is spending the most expensive hours of her week - clinically, intellectually, emotionally - on a task that is essentially organisational. The patient is paying, in time and money, for those same hours. And the structured case that should have arrived on the consultant's desk before the patient did, has not.
The clinical capacity in this country is, by any honest measure, world-class. The tertiary centres train as well as anywhere. The senior consultants would hold their own in any tumour board on any continent. The subspecialty depth - breast, head and neck, gastrointestinal, paediatric, lymphoma - has matured in two decades to a standard that earlier generations would not have predicted.
What has grown more quietly, and at a different pace, is the connective tissue around all this clinical capacity. The records layer. The case-structuring layer. The matching layer that helps a patient reach the right subspecialist on the first attempt. The data layer that learns, anonymously, from the millions of cases that pass through Indian hospitals each year.
This is not a failing. It is a sequence. Clinical capacity comes first; the connective tissue follows. India is now, perhaps, at the moment where the second part of that sequence becomes possible.
Imagine the same Tuesday morning, with one small change. The folder is still there, but alongside it sits a structured view of the case. The diagnosis, the stage, the histology, the receptor status, the prior treatments, the response, the unanswered questions - all on a single page, read once, verified by a human before it reached the consultant.
The ninety minutes of records review compress into eight. The conversation expands. The patient leaves with clarity, not just with a prescription. The consultant has spent her expensive hours on the work only she can do.
Multiply this small change by a country's worth of OPDs. The arithmetic, when one sits with it for a while, is not small.
A small team, working out of Ahmedabad, has spent the past few months building the connective tissue described above. The platform is now live, in early operation, with a founding cohort of specialists beginning to take cases on it.
The architecture is in three layers. Two of them matter most for the oncology hospital reading this page; the third is mentioned briefly for completeness.
Clinical Intelligence is what relieves the daily clinical reality. The Knowledge Layer is what ensures every case is read against the best available evidence - guidelines, trials, concordance. These two together are the part of this work most worth pausing on.
Imagine the senior consultant five years from now. Her OPD still reads twenty-three. The records still arrive in many forms. But every case now reaches her structured. She spends her hours on what only she can do - the judgement, the explanation, the human bond with the patient sitting across from her.
Imagine, alongside that, an Indian oncology dataset that has grown quietly from the work - a million cases structured and queryable, under appropriate governance. A research substrate that any tertiary institution can draw from. Decision-quality studies that are no longer impossible to run because the data exists, organised, in one place. Younger oncologists training on real Indian case-mix structured to international standards.
None of this is a single product's promise. It is the trajectory of a layer of infrastructure that, once present, quietly compounds.
This is what the work looks like, today, at its earliest stage. A small team. A platform that is live. A founding cohort of specialists. A few hundred cases moving through it. An architecture chosen carefully - Clinical Intelligence at the front, the Knowledge Layer beneath it, Matchmaking Intelligence between them.
What it will become depends, more than on anything else, on whether the institutions and the senior clinicians of Indian oncology find it worth their attention. The page above is not a pitch. It is an open observation - gratefully written, gently held - about what might be possible if this layer of connective tissue is built well.
We would be honoured to share more, with anyone willing to look at it carefully.